TORONTO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free ...

At close: January 14 at 3:59:30 p.m. EST ...

Fourth quarter revenue growth estimated at 105% to 110% year-over-year - - Company to start reporting in accordance with U.S. GAAP and filing with the SEC on U.S. domestic forms - - Profound reminds ...